slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 36,121-36,150
Pages 1,935
Rows per page 30
Slide function
36,121-36,150 of 58,039
04
Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slidesAeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Situation & Context1 hit
19
The chart shows dose-response curves for cell binding. The table summarizes EC50 values.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
20
The chart shows a biphasic exponential decay curve for three datasets.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
21
The chart uses a regression line to correlate human and NHP half-lives, highlighting the 3.1x multiplier for YTE-modified antibodies.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
24
Data from GEMINI 1 study; compares Q8W and Q4W dosing regimens.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
38
The slide uses a bar chart to illustrate additive clinical remission rates, with a table below providing additional clinical metrics (N, maintenance remission, safety).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
34
Includes definitions for COPD, nOH, and PTE in the footer.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
36
The table displays projected royalties and milestones for 2023-2026, while the right side details royalty return dates for 2029 and 2031.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
37
The slide uses two distinct colored containers to contrast the two different drug deal structures.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
05
The slide uses a waterfall bridge to reconcile equity adjustments between two entities.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
06
The table highlights that these adjustments are CET1 neutral.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
07
The slide provides a breakdown of mark-downs and mark-ups for various asset classes, including loans, real estate, and software, following IFRS 3 acquisition rules.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
08
The table breaks down impacts on Assets, Liabilities, Equity, and CET1 capital.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
10
This is a financial disclosure table detailing the accounting adjustments made during the Credit Suisse acquisition.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
06
2020 data is omitted due to COVID-19 pandemic.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
08
The slide includes a footnote defining Marketplace GOV.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
09
Includes margin percentages overlaid on bar charts.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
10
Includes a non-GAAP disclaimer footnote.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · Financials1 hit
16
The slide explains the dual-class structure and how it relates to financial reporting and economic interest.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
17
Data presented in thousands, except for per-share amounts.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
18
The chart includes a trend line showing a 3-4% CAGR over the period.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
19
The table includes footnotes (1-8) for specific line items.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
05
Data source: China National Bureau of Statistics (CNBS).Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide highlights improvements in skincare revenue, gross margin, S&M expense efficiency, and a shift to GAAP profitability.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
08
Includes revenue from DR.WU (mainland China), Galénic, Eve Lom, Abby's Choice, and others.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Loop · So What Cascade1 hit
10
The chart highlights a strategic reduction in offline retail footprint throughout 2022.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations 1 hit
12
Data shows a decline in revenue but an improvement in gross margin.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
13
The slide explains the drivers behind the reduction in G&A and S&M expenses, specifically citing share-based compensation reversals and store closures.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
14
Includes a footnote explaining the non-GAAP definition and methodology.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
15
The chart displays quarterly operating cashflow as bars and the total cash balance as oval-enclosed numbers above the bars.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit